Dr Adam Januszewski· @AdamJanuszewski · X·· 14 小时前评分70
正文 · 原文
🚨 #ESMO26 SANOVO Ph3 🇨🇳 (China-only)
Impressive 1L savolitinib + osimertinib in EGFRm/MET-OE NSCLC:
📈 PFS 24.9 vs 13.8m (HR 0.56)
📈 OS 44.5 vs 34.9m (HR 0.48)
MET is a key target!
❓Target MET in 1L or 2L? Amivantimab already targets MET. Efficacy similar. Tox will be key
2 浏览 · 0 赞 · 0 转发 · 0 回复
来源：Dr Adam Januszewski · x.com